A new, automatic capsule filling system produced by Italian manufacturer MultiPharma is now available exclusively in the UK from Glenvale Packaging.
The MultiPharma V10 system is the first new machine to be introduced into the UK since Northamptonshire-based Glenvale Packaging was appointed to distribute MultiPharma’s products.
The totally enclosed V10 system is suitable for handling potent products and can process up to 9,000 capsules/hr. It has a footprint of 90x110cm and, owing to fitted castors, can be moved around a production facility.
‘The design is ideal for handling hard shell capsules – both gelatine and vegetarian options,’ said Garry Coleman, partner at Glenvale Packaging.
‘It is supplied fully specified to handle the desired capsule size. Additional accessories can then also be fitted to accommodate size changes as needed.’
The unit only requires air and electrical connections and is operated by a touchscreen that can be positioned to suit the operator’s needs. The anodised, aluminium construction meets GMP regulatory requirements.
‘The V10 has already been proven in Europe,’ added Coleman. ‘It is suited to a range of applications – from clinical trials in the health industry through to small manufacturing operations.’
Glenvale Packaging introduces MultiPharma V10 in the UK
An automatic capsule filling machine that handles potent products
You may also like
Trending Articles
You may also like
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing
Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering